Liver
Transplants
What is liver transplantation?
Liver transplantation is a life-saving operation for children and
adults with certain liver diseases when no other treatment is available.
The operation involves taking out the diseased liver and replacing
it with a liver of suitable size and blood type. Overall, about 60-75
of adult patients and 80-90% of children survive a liver transplantation
and resume normal lives although they continue to need medication
to prevent rejection.
Unfortunately, many patients succumb to liver disease before transplantation
can be undertaken. Public awareness of the need for organ donation
is an important element in the overall success of liver transplantation.
Which liver diseases are the most common?
The majority of patients who come to liver transplantation with
chronic liver disease have developed cirrhosis of the liver. Cirrhosis
refers to scarring of the liver and this results in abnormalities
in the function of the liver. These abnormalities may threaten the
patient's life and usually include problems with bleeding and infections.
Patients who develop acute liver disease may require urgent transplantation
and often have no prior history of liver disease. These patients
may develop liver failure with serious blood clotting abnormalities
as well as deep coma. Without urgent transplantation, most patients
with acute liver diseases will die. In adult patients, causes of
chronic liver disease leading to cirrhosis include viral hepatitis
(usually type B or type C), alcohol related liver disease, and autoimmune
liver diseases including primary biliary cirrhosis and acute fulminant
liver failure (adults and children)
What diseases are treated by liver transplantation?
Liver transplants may be performed for a number of acute or chronic
liver diseases. Patients with acute liver diseases usually require
urgent transplantation within a matter of days to weeks. Patients
with chronic liver disease may undergo elective liver transplantation
unless they experience worsening of their liver disease, in which
case, urgent transplantation may be required in these patients.
What about children and liver disease?
Thousands of children, from infants to adolescents, have liver
disease, and many die from it each year. Some are born with a liver
disease, others contract it at birth or early in life. The more common
types of liver diseases that affect children are: chronic active
hepatitis, Biliary Atresia, galactosemia, Wilson disease, alpha-1antitrypsin
deficiency, tyrosinemia and Reye's syndrome.
Advances in liver transplantation offer hope for children with
severe, irreversible liver disease.
What about cancer of the liver?
Cancers of the liver are not usually treated with transplantation.
Most liver cancers begin elsewhere in the body and spread to the
liver. These patients are not curable with liver transplantation.
Unfortunately, most liver tumors or cancers that have started in
the liver usually grow to large size without being detected and are
therefore rarely curable by liver transplantation. Many liver transplant
centers, however, have protocols to treat patients who have small
or early stage cancers with transplantation and chemotherapy.
There is still much to be learned about cancer that originates
in the liver. Liver cancer can be caused by hepatitis B, which is
probably the major cause of liver cancer worldwide. It is often associated
with cirrhosis and can be caused by certain parasites, drugs and
environmental toxins.
Is liver transplant a last resort, when everything else has failed?
It is well known that liver transplantation is highly successful
if performed prior to patients becoming critically ill. If the patients
are allowed to deteriorate to the terminal stages of their liver
disease, the success of liver transplantation is poor. However, if
other medical or surgical options are available for the patients
which will either restore them to or maintain them in a good to excellent
quality of life, then transplantation should be delayed. An additional
factor in the decision about the timing of referral of a patient
for transplant is the fact that even after a patient is placed on
the national waiting list for a liver transplant, the time it takes
to find a suitable donor liver can be over a year for some patients.
How is the decision made to transplant?
The decision to transplant is made in consultation of all individuals
involved including the patient and/or family with a clear understanding
of the risks involved.
The decision that a patient is a suitable candidate for transplantation
involves an evaluation by the liver transplant team. This usually
involves traveling to the transplant center and meeting with the
physicians and surgeons as well as the transplant coordination's,
social workers, dietitians, and other members of the transplant team.
After the evaluation of the patients is completed most transplant
centers have a medical review board which reviews the data on every
patient who is a candidate for transplant. If no contraindications
are discovered, the committee will approve the patient as a transplant
candidate. Once approved, then patients are placed on the national
waiting list.
What are the major risks before, during and after transplantation?
Before the transplant, the major risk is the development of severe
complications of the liver disease. These complications may result
in the patient's death or complications may develop which render
a patient an unacceptable risk for transplantation. The risks associated
with transplant surgery are common to all forms of major surgery
and include bleeding and infection. Unique to liver transplantation
is the difficulty in removing the diseased liver, especially in patients
who have had prior operations on their liver or gallbladder. Additionally,
major blood vessels must be connected in order to transplant the
donor liver. Clotting of these vessels may result in severe damage
to the transplanted liver with need for a second liver transplant.
The function of the transplanted liver must also be good to excellent
or the patient will not recover. Late complications which may develop
in patients who have received a liver transplant include rejection,
a variety of infections, or complications related to the anti-rejection
drugs.
What are the overall chances of surviving a liver transplant?
This depends on many factors, but approximately 75% of all patients
coming to liver transplantation survive the first year after transplantation.
Most centers report that over 95% of their patients who survive the
first year survive each year after the first. However, patients who
are in good condition going into the transplant have survival rates
of as high as 90% at one year, patients who are critically ill and
confined to the Intensive Care Unit have survival rates of less than
50%. This again indicates the importance of early referral of patients
for transplantation and the need to transplant patients before they
become critically ill.
How long does it take to recover?
Recovery time depends in large part on how ill the patient was
prior to their transplant and how well the transplanted liver works
after the transplant. Most patients who are admitted to the hospital
from home for their transplant will spend 2-3 days in the Intensive
Care Unit and 2-3 weeks in the hospital. Patients who are critically
ill at the time of their transplant may spend 2-3 weeks in the Intensive
Care Unit and 2-3 months in the hospital.
What happens during this recovery period?
While patients are in the Intensive Care Unit, there is very careful
monitoring of all body functions. Once patients are sent to the transplant
ward, they are usually beginning to resume eating a normal diet as
well as being out of bed and walking in the halls. In addition to
physical therapy and intensive nutritional support, patients will
be changing from anti-rejection medicines given by vein to anti-rejection
medicines taken exclusively by mouth. As the patient's condition
stabilizes and their liver function normalizes, the frequency that
blood tests need to be taken decreases. Additionally, as time passes,
the liver requires less anti-rejection medicine to prevent rejection
and the frequency of lab work may decrease from three times a week
to as infrequently as once a month within the first year after transplant.
If the transplanted liver fails to function, or is rejected, what
can be done?
The degree of liver failure may vary from patient to patient. Patients
with severe liver failure due either to rejection, clotting of blood
vessels, or poor initial function of the transplant will often require
a second transplant. It is rare for a third or fourth transplant
to be performed. As of yet, there is no artificial liver device which
is clinically available for routine use. However, most patients who
develop rejection can be treated and, in most cases, the transplanted
liver will respond and a second transplant will not be necessary.
What side effects do patients commonly experience from medications
used to prevent rejection?
All the medicines used to prevent rejection increase the patient's
susceptibility to infections and all transplant recipients on anti-rejection
medicine are more prone to develop certain types of cancers. Each
medication has its own side effects. Steroids can cause fluid retention,
puffiness of the face, worsening of diabetes, and bone loss (osteoporosis).
Cyclosporine and Prograf can cause kidney damage as well as high
blood pressure. All patients should be informed of the possible side
effects. All patients will be educated about how to take care of
their transplants and all patients will be educated about how to
take their anti-rejection medication, as well as what side effects
to look out for.
Do recipients of liver transplants take medicines for the rest of
their lives?
Yes. It appears most likely that all patients undergoing liver
transplantation will require anti-rejection medicines for the rest
of their lives. However, over time, the amount of anti-rejection
medicine becomes less as the body becomes more tolerant of the transplanted
liver. Most centers attempt to lower the amount of anti-rejection
medicine to the smallest dose required to prevent rejection in all
transplant recipients. Some centers are also selectively eliminating
one or more of the anti-rejection medicines. If this is to be done,
it must be done under close supervision by the transplant center.
Are patients more susceptible to other infections?
Once the patient has stabilized after their transplant, they are
not receiving such high doses of anti-rejection medication that they
are likely to pick up serious infections from individuals around
them. However, they are at high risk for developing infection from
organisms that reside in their own body. Most centers require that
transplant recipients take long-term antibiotics by mouth to prevent
certain unusual types of lung infections. In addition, they may be
required to take anti-viral medications, especially if they have
developed a viral infection following their transplant. Most important
is the fact those patients who are on anti-rejection medications
are at higher risk of becoming seriously ill with any infection.
Therefore, any significant illness should be reported immediately
to either the primary care physician or the liver transplant team.
No over-the-counter medications should be taken without approval
of the transplant team.
What about physical activity after the transplant?
Most patients are able to return to normal or near-normal quality
of life after their transplant. There is absolutely no reason patients
with a well-functioning transplant cannot participate in vigorous
physical exercise within three to six months after their successful
transplant. Many liver transplant recipients take part in the National
and Regional Transplant Olympics which are held yearly.
What about sexual activity?
As with other physical activities, sexual activity may be resumed
when desired. Birth control should be used when appropriate in sexually
active transplant recipients. Many women who have lost their menstrual
periods due to the severity of their liver disease will begin to
have periods again once they have recovered from their transplant.
Can there be a recurrence of the original disease in the transplanted
liver?
If hepatitis, either B or C, caused the liver disease, then recurrences
are likely. Other types of liver disease do not usually recur following
successful transplantation.
From the description, patients with successful liver transplants
seem very healthy. How long can this good health last?
It is the impression of most transplant surgeons and physicians
that a patient's life-span should not be significantly decreased
by the fact that they underwent a liver transplant. Probably because
of the unique ability of the liver to repair itself from minor damage,
there is no reason to assume that a transplanted liver cannot function
adequately for an indefinite period of time. It is important to stress,
however, that patients with a transplant continue to be at risk of
complications throughout their life. Long-term medical follow-up
is therefore required of all patients who have undergone transplantation.